Teradyne shares dropped 7.4% to $436.86 on June 26, erasing most of the prior session's AI-driven gains as valuation concerns resurfaced.
Teradyne Inc. shares fell 7.4% to $436.86 on June 26, giving back most of the prior session's gains as investors weighed elevated valuation against the semiconductor test company's AI growth prospects.
"Teradyne's current price sits 160% above our GF Value estimate of $168.04, suggesting the stock is significantly overvalued," GuruFocus analysts wrote. The company's trailing P/E of 80.9x compares with a five-year median of 30.3x.
The decline followed a 10.5% surge on June 25, when Teradyne rallied in sympathy with customer Micron Technology's blowout results. Micron reported fiscal third-quarter revenue of $41.5 billion, well above the $36.5 billion consensus. The memory maker's strong high-bandwidth memory demand was seen as a positive signal for Teradyne's test equipment orders. However, the stock's valuation rank of 1 out of 10 on GuruFocus's GF Score framework underscored the disconnect between price and fundamentals.
Teradyne now faces a critical test on July 28, when it reports fiscal second-quarter results. The company guided revenue of $1.15 billion to $1.25 billion, a sequential decline from $1.28 billion in Q1. With the stock trading above the Street's mean target of about $390, the earnings print will determine whether the AI testing thesis can support the premium.
Insider Selling Adds to Caution
Company insiders sold $6.7 million worth of shares over the past three months with no purchases recorded, according to GuruFocus data. The selling pattern suggests those closest to the business saw limited upside at current levels.
The valuation gap is stark even within the semiconductor equipment peer group. Teradyne trades near 50 times next-twelve-months enterprise value to EBITDA, compared with about 36 times for closest rival Advantest Corp. and 39 times for Applied Materials Inc. Bulls argue the premium is justified by Teradyne's outsized exposure to high-bandwidth memory testing, where test intensity rises sharply with each DRAM stack. Chief Executive Officer Gregory Smith said at the BofA Global Technology Conference that for DRAM going into HBM, "the test intensity for that is much higher because of the stacking and the quality requirements downstream."
Bank of America raised its price target on Teradyne to $525 from $365 this week, maintaining a buy rating. The broader analyst consensus remains split, with 11 buy ratings, five holds and one sell, according to TIKR data.
This article is for informational purposes only and does not constitute investment advice.